Finance

Roʻyxatlar
Istiqbol: 52.0% optimistik·16.0% pessimistik
Tahlilga kirish
SYK:NYSE
Stryker Corp
294,66 US$
+0,49%
(+1,43) 1K
295,00 US$
+0,12% (+0,34)
Yopilgandan keyin
Savdolar yopilgan: 16-okt, 16:02:04 (GMT-4)  ·   USD
Barcha belgilar
BelgiNarxiOʻzgartirishlarDinamika (%)
SYK tikeri uchun statistika yaratilmoqda...
Ochish
295,89 US$
Yuqori
299,67 US$
Past
293,75 US$
Bozor kapitali
113,02 mlrd
Oʻrtacha hajm
2,93 mln
Hajmi
3,38 mln
Dividend
1,19%
Choraklik dividendlar
0,88 US$
Eks-dividend sanasi
30-sen, 2026
P/E koeffitsiyenti
30,53
52 haftalik eng yuqori
392,55 US$
52 haftalik eng past
267,00 US$
Aksiya boʻyicha daromad
9,65 US$
Beta
0,77
Muomaladagi aksiyalar
383,57 mln
Xodimlar soni
56 ming
Ochish
295,89 US$
Yuqori
299,67 US$
Past
293,75 US$
Bozor kapitali
113,02 mlrd
Oʻrtacha hajm
2,93 mln
Hajmi
3,38 mln
Dividend
1,19%
Choraklik dividendlar
0,88 US$
Eks-dividend sanasi
30-sen, 2026
P/E koeffitsiyenti
30,53
52 haftalik eng yuqori
392,55 US$
52 haftalik eng past
267,00 US$
Aksiya boʻyicha daromad
9,65 US$
Beta
0,77
Muomaladagi aksiyalar
383,57 mln
Xodimlar soni
56 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Profil
Stryker Corporation is an American multinational medical technologies corporation based in Portage, Michigan, United States. The company's products are used for medical surgery and neurotechnology, which include surgical equipment, patient and caregiver safety technologies, endoscopy systems, and patient handling, emergency medical equipment, and intensive care disposable products, as well as neurosurgical, neurovascular and oral and maxillofacial surgery implant products; and orthopedic surgery, which includes implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. Stryker's products are sold in over 75 countries and are used by 150 million patients annually. In 2024, 75% of the company's revenues came from the United States. The company is ranked 195th on the Fortune 500 and 331st on the Forbes Global 2000. Wikipedia
Stryker Corp haqida
CEOKevin A. Lobo
Xodimlar soni56 ming
Asos solingan1941
Bosh ofislarKalamazoo, Michigan, Amerika Qo‘shma Shtatlari
Sektor-
Veb-saytstryker.com
Analitik reytinglar
Oxirgi 3 oyda SYK aksiyalari boʻyicha reyting bergan 20 tahlilchi xulosasiga koʻra
Sotib olish tavsiya etiladi
Sotib olish
18
Ushlab qolish
2
Sotish
0
12 oylik prognoz
Oxirgi 3 oyda SYK uchun 12 oylik narx maqsadlarini taklif qilgan 20 Wall Street tahlilchisi xulosasiga koʻra
Eng yuqori
Joriy 294,66 US$
420,00 US$ (+42,54%)
O‘rtacha
364,72 US$ (+23,78%)
Eng past
298,00 US$ (+1,13%)
Analitik
Tavsiya
Amal
Kutilayotgan narx
Prognoz
Sana
Vik Chopra
BMO Capital
Buy
Maintained
317,00 US$
+7,6%
10/12/2026
Caitlin Roberts
Canaccord Genuity
Buy
Reiterated
385,00 US$
+30,7%
10/13/2026
Christopher Pasquale
Barclays
Buy
Maintained
375,00 US$
+27,3%
10/13/2026
Ryan Zimmerman
BTIG
Buy
Maintained
316,00 US$
+7,2%
10/12/2026
Mike Kratky
Leerink Partners
Buy
Reiterated
353,00 US$
+19,8%
10/12/2026
Joanne Wuensch
Citi
Buy
Maintained
-
-
10/07/2026
Travis Steed
Bank of America Securities
Buy
Maintained
380,00 US$
+29%
10/06/2026
Matt Miksic
Barclays
Buy
Maintained
375,00 US$
+27,3%
10/07/2026
Richard Newitter
Truist Financial
Hold
Maintained
310,00 US$
+5,2%
10/06/2026
Michael Matson
Needham
Buy
Maintained
418,00 US$
+41,9%
10/06/2026
Kendall Au
RBC Capital
Buy
Maintained
420,00 US$
+42,5%
10/01/2026
Rick Wise
Stifel Nicolaus
Buy
Maintained
330,00 US$
+12%
09/30/2026
Matthew Taylor
Jefferies
Buy
Maintained
405,00 US$
+37,4%
09/22/2026
Mathew Blackman
TD Cowen
Hold
Reiterated
298,00 US$
+1,1%
09/22/2026
William Plovanic
Canaccord Genuity
Buy
Reiterated
385,00 US$
+30,7%
09/18/2026
Shagun Singh Chadha
RBC Capital
Buy
Reiterated
420,00 US$
+42,5%
09/16/2026
Larry Biegelsen
Wells Fargo
Buy
Reiterated
348,00 US$
+18,1%
09/16/2026
Steven Lichtman
William Blair
Buy
Reiterated
-
-
09/09/2026
Robbie Marcus
J.P. Morgan
Buy
Maintained
350,00 US$
+18,8%
08/04/2026
David Turkaly
Citizens JMP
Buy
Maintained
400,00 US$
+35,7%
08/03/2026
Jayson Bedford
Raymond James
Buy
Maintained
370,00 US$
+25,6%
07/31/2026
Matthew O'Brien
Piper Sandler
Buy
Maintained
390,00 US$
+32,4%
07/31/2026
Patrick Wood
UBS
Buy
Upgraded
400,00 US$
+35,7%
07/28/2026
David Toung
Argus Research
Buy
Reiterated
370,00 US$
+25,6%
07/09/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
418,00 US$
+41,9%
07/08/2026
Unknown Analyst
BMO Capital
Buy
Initiated
369,00 US$
+25,2%
07/09/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
350,00 US$
+18,8%
07/06/2026
David Roman
Goldman Sachs
Hold
Maintained
361,00 US$
+22,5%
05/01/2026
Jeff Johnson
Robert W. Baird
Buy
Maintained
385,00 US$
+30,7%
05/01/2026
Pito Chickering
Deutsche Bank
Hold
Maintained
315,00 US$
+6,9%
05/01/2026
Lee Hambright
Bernstein
Buy
Maintained
410,00 US$
+39,1%
05/01/2026
Nico Chen
DBS
Buy
Maintained
450,00 US$
+52,7%
03/18/2026
Danielle Antalffy
UBS
Hold
Reiterated
380,00 US$
+29%
03/17/2026
Unknown Analyst
Jefferies
Buy
Maintained
465,00 US$
+57,8%
03/05/2026
Keyingi hisobot: 13 kundan keyin
Pay, 29-okt, 22:30
Moliya davri
Ch.3 2026
- / 3,53 US$
Taxminiy daromad (USD)
- / 6,62 mlrd
Q3 2026 uchun tushumlar hisoboti
Tushumlar hisoboti kutilmoqda
Qisqacha: kelgusi tushumlar
Oxirgi yangiliklar va hisobotlar sarhisobi
Avvalgi hisobotlarBarcha qiymatlar – USD
Loading Previous Earnings...
Daromad
Sof foyda
Barcha qiymatlar – USD
sen, 2025
dek, 2025
mar, 2026
iyn, 2026
Daromad
6,06 mlrd
7,17 mlrd
6,02 mlrd
6,59 mlrd
Sotilgan mahsulotning tannarxi
2,12 mlrd
2,49 mlrd
2,19 mlrd
2,08 mlrd
Daromad narxi
2,12 mlrd
2,49 mlrd
2,19 mlrd
2,08 mlrd
Tadqiqot va ishlanmalarga xarajatlar
409,00 mln
388,00 mln
409,00 mln
429,00 mln
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar
-
-
-
-
Tijoriy, umumiy va maʼmuriy xarajatlar
1,99 mlrd
2,15 mlrd
2,16 mlrd
2,13 mlrd
Operatsion xarajatlar
2,58 mlrd
2,72 mlrd
2,75 mlrd
2,73 mlrd
Jami operatsion xarajatlar
4,71 mlrd
5,22 mlrd
4,95 mlrd
4,81 mlrd
Operatsion daromad
1,35 mlrd
1,95 mlrd
1,07 mlrd
1,78 mlrd
Boshqa nooperatsion daromad
-138,00 mln
420,00 mln
19,00 mln
1,00 mln
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar
1,03 mlrd
1,70 mlrd
850,00 mln
1,56 mlrd
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno
1,25 mlrd
1,81 mlrd
987,00 mln
1,68 mlrd
Daromad soligʻi boʻyicha xarajat
170,00 mln
856,00 mln
105,00 mln
288,00 mln
Amaldagi soliq stavkasi
16,52%
50,21%
12,35%
18,41%
Boshqa operatsion xarajatlar
-
-
-
-
Sof foyda
859,00 mln
849,00 mln
745,00 mln
1,28 mlrd
Sof foyda marjasi
14,18%
11,84%
12,38%
19,37%
Har bir aksiya foydasi
3,19
4,47
2,60
3,69
Foizlar va investitsiyalardan olingan daromadlar
28,00 mln
31,00 mln
34,00 mln
26,00 mln
Foizlarni toʻlash xarajatlari
-
-607,00 mln
-148,00 mln
-141,00 mln
Foizlarni toʻlash boʻyicha sof xarajatlar
28,00 mln
-576,00 mln
-114,00 mln
-115,00 mln
Amortizatsiya ajratmalari
-
-
-
-
EBITDA
1,66 mlrd
2,27 mlrd
1,37 mlrd
2,08 mlrd
Aktivlarni sotishdan olingan foyda yoki zarar
-
-
-
-
Insayder tranzaksiyalari
Insayder tranzaksiyalari maʼlumotlari tashqi manbalardan olingan. Batafsil
Insayder
Joylashuvi
Turi
Sana
Aksiyalar
Miqdor
1-sahifa
AI kontentda xatolar boʻlishi mumkin. Batafsil
Google ilovalari